Answers are grounded in this paper and cite their sources.
Human liver organoids are useful for modeling steatotic liver injury and exploring disease-related mechanisms. This study examined the role of negative elongation factor E (NELFE) in metabolic dysfunction-associated steatotic liver disease (MASLD)-like injury using human liver organoids, clinical liver samples, transcriptome analysis, and HFD-fed mice. Human liver organoids were generated from liver tissues and treated with free fatty acids (FFA) to establish a MASLD-like model. Transcriptome sequencing was performed to identify differentially expressed genes and enriched pathways. NELFE expression was examined in FFA-treated organoids, clinical samples, and public datasets. NELFE function was evaluated by lentivirus-mediated knockdown and overexpression, together with Oil Red O staining, biochemical assays, ATP-based viability analysis, and Western blotting. Luciferase reporter assays, ChIP-qPCR, AKT activation, and HFD-fed mouse experiments were used for mechanistic and in vivo validation. FFA treatment induced lipid accumulation and increased injury-, inflammation-, and fibrosis-related indicators in human liver organoids. NELFE expression was increased in FFA-treated organoids and MASLD liver samples. NELFE knockdown was associated with reduced lipid accumulation and injury-related indicators, whereas NELFE overexpression was associated with aggravated FFA-induced lipid deposition and biochemical changes. Transcriptome analysis after NELFE knockdown identified FFA-responsive and NELFE-associated genes enriched in several pathways, including PI3K/AKT signaling. NELFE knockdown was associated with reduced AKT3, PIK3AP1, p-AKT/AKT, and p-mTOR/mTOR levels under FFA exposure. Luciferase reporter assays and ChIP-qPCR supported an association between NELFE and the promoter regions of AKT3 and PIK3AP1. AKT activation partially reversed the effects of NELFE knockdown. In HFD-fed mice, the HFD + shNELFE group showed lower hepatic lipid accumulation, liver injury markers, serum inflammatory cytokines, apoptotic signals, and PI3K/AKT-associated pathway activity than the HFD group. NELFE is upregulated in MASLD-related models and clinical liver samples. These findings suggest that NELFE may contribute to MASLD-like steatotic liver injury, at least partly through PI3K/AKT-associated signaling.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: